Chemoinformaics analysis of (2-hydroxy-4(1H)-quinolinone)
Molecular Weight | 207.204 | nRot | 1 |
Heavy Atom Molecular Weight | 197.124 | nRig | 12 |
Exact Molecular Weight | 207.07 | nRing | 2 |
Solubility: LogS | -3.077 | nHRing | 1 |
Solubility: LogP | 2.143 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 28.2989 |
nHD | 1 | BPOL | 13.4511 |
QED | 0.75 |
Synth | 2.555 |
Natural Product Likeliness | -0.568 |
NR-PPAR-gamma | 0.198 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.002 |
HIA | 0.015 |
CACO-2 | -4.654 |
MDCK | 0.0000236 |
BBB | 0.262 |
PPB | 0.842942 |
VDSS | 0.695 |
FU | 0.0663175 |
CYP1A2-inh | 0.968 |
CYP1A2-sub | 0.945 |
CYP2c19-inh | 0.28 |
CYP2c19-sub | 0.079 |
CYP2c9-inh | 0.345 |
CYP2c9-sub | 0.704 |
CYP2d6-inh | 0.75 |
CYP2d6-sub | 0.389 |
CYP3a4-inh | 0.116 |
CYP3a4-sub | 0.191 |
CL | 2.468 |
T12 | 0.453 |
hERG | 0.009 |
Ames | 0.344 |
ROA | 0.902 |
SkinSen | 0.284 |
Carcinogencity | 0.374 |
EI | 0.551 |
Respiratory | 0.919 |
NR-Aromatase | 0.034 |
Antiviral | No |
Prediction | 0.702128 |